FTM
First Turn Management Portfolio holdings
AUM
$536M
This Quarter Return
-0.25%
1 Year Return
+36.36%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$496M
AUM Growth
+$496M
(-11%)
Cap. Flow
-$27.5M
Cap. Flow
% of AUM
-5.54%
Top 10 Holdings %
Top 10 Hldgs %
46.81%
Holding
44
New
8
Increased
12
Reduced
13
Closed
9
Top Buys
| 1 |
Boston Scientific
BSX
|
$18M |
| 2 |
TG Therapeutics
TGTX
|
$15.8M |
| 3 |
Guardant Health
GH
|
$13.5M |
| 4 |
SWTX
SpringWorks Therapeutics
SWTX
|
$13.4M |
| 5 |
Insulet
PODD
|
$13M |
Top Sells
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$24.6M |
| 2 |
Crinetics Pharmaceuticals
CRNX
|
$23.2M |
| 3 |
Geron
GERN
|
$13.8M |
| 4 |
VRNA
Verona Pharma
VRNA
|
$13.1M |
| 5 |
Day One Biopharmaceuticals
DAWN
|
$12M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Insmed
INSM
$28.8B
| $30.6M | 6.18% |
401,629
-45,351
| -10% | -$3.46M |
|
|
VRNA
2
Verona Pharma
VRNA
$9.16B
| $27.6M | 5.57% |
435,385
-206,516
| -32% | -$13.1M |
|
3
argenx
ARGX
$43.6B
| $24.8M | 5% |
41,911
-1,167
| -3% | -$691K |
|
4
Nuvalent
NUVL
$5.52B
| $23.5M | 4.75% |
331,927
+22,406
| +7% | +$1.59M |
|
5
Xenon Pharmaceuticals
XENE
$2.98B
| $22.9M | 4.62% |
683,451
-1,535
| -0.2% | -$51.5K |
|
6
BridgeBio Pharma
BBIO
$9.89B
| $22.7M | 4.58% |
656,699
+204,409
| +45% | +$7.07M |
|
7
Mirum Pharmaceuticals
MIRM
$3.71B
| $22.7M | 4.57% |
503,014
-3,894
| -0.8% | -$175K |
|
8
Natera
NTRA
$23.1B
| $19.8M | 3.99% |
139,942
+40,783
| +41% | +$5.77M |
|
9
Merus
MRUS
$4.98B
| $19.5M | 3.94% |
463,960
+178,801
| +63% | +$7.53M |
|
|
10
Boston Scientific
BSX
$156B
| $18M | 3.62% |
+178,156
| New | +$18M |
|
11
Ascendis Pharma
ASND
$11.8B
| $17.7M | 3.56% |
113,278
+25,474
| +29% | +$3.97M |
|
|
12
TG Therapeutics
TGTX
$4.65B
| $15.8M | 3.18% |
+400,644
| New | +$15.8M |
|
13
Vera Therapeutics
VERA
$1.38B
| $15M | 3.02% |
623,612
+158,805
| +34% | +$3.81M |
|
14
Axsome Therapeutics
AXSM
$6.05B
| $13.8M | 2.78% |
118,179
-73,967
| -38% | -$8.63M |
|
|
15
Guardant Health
GH
$8.41B
| $13.5M | 2.71% |
+315,737
| New | +$13.5M |
|
|
SWTX
16
DELISTED
SpringWorks Therapeutics
SWTX
| $13.4M | 2.71% |
+304,076
| New | +$13.4M |
|
17
Glaukos
GKOS
$5.5B
| $13.4M | 2.7% |
136,241
+40,144
| +42% | +$3.95M |
|
18
Exact Sciences
EXAS
$8.98B
| $13M | 2.63% |
300,909
-8,981
| -3% | -$389K |
|
|
19
Insulet
PODD
$23.9B
| $13M | 2.61% |
+49,350
| New | +$13M |
|
20
Revolution Medicines
RVMD
$7.1B
| $12M | 2.42% |
340,109
-63,806
| -16% | -$2.26M |
|
21
Janux Therapeutics
JANX
$1.37B
| $11.6M | 2.34% |
430,163
+46,561
| +12% | +$1.26M |
|
22
Oric Pharmaceuticals
ORIC
$994M
| $11.3M | 2.28% |
2,027,430
+576,393
| +40% | +$3.22M |
|
23
ADMA Biologics
ADMA
$4.12B
| $11.2M | 2.27% |
566,945
-117,285
| -17% | -$2.33M |
|
24
Intuitive Surgical
ISRG
$170B
| $10.9M | 2.21% |
22,109
-12,923
| -37% | -$6.4M |
|
25
Enliven Therapeutics
ELVN
$1.2B
| $10.5M | 2.12% |
535,092
| – | – |
|